Supplemental

Taxes Paid

Moderna Taxes Paid remained flat by 0.0% to $6.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 86.8%, from $49.25M to $6.50M. Over 4 years (FY 2021 to FY 2025), Taxes Paid shows a downward trend with a -51.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionSupplemental
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2025Feb 20, 2026

How to read this metric

High cash taxes relative to earnings may indicate limited tax planning opportunities or specific jurisdictional tax requirements.

Detailed definition

The actual cash outflow for income taxes during the period, which may differ from the tax expense reported on the income...

Peer comparison

Comparable across peers in the same tax jurisdictions; useful for calculating effective cash tax rates.

Metric ID: income_taxes_paid

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$480.00M$2.73B-$357.00M$197.00M$26.00M
YoY Change+468.5%-113.1%+155.2%-86.8%
Range-$357.00M$2.73B
CAGR-51.8%
Avg YoY Growth+106.0%
Median YoY Growth+34.2%

Frequently Asked Questions

What is Moderna's taxes paid?
Moderna (MRNA) reported taxes paid of $6.50M in Q4 2025.
How has Moderna's taxes paid changed year-over-year?
Moderna's taxes paid decreased by 86.8% year-over-year, from $49.25M to $6.50M.
What is the long-term trend for Moderna's taxes paid?
Over 4 years (2021 to 2025), Moderna's taxes paid has grown at a -51.8% compound annual growth rate (CAGR), from $480.00M to $26.00M.
What does taxes paid mean?
The actual cash paid to tax authorities during the period.